您好,可參考此篇文獻:pubmed.ncbi.nlm.nih.gov/32065376/ Silymarin, an extract from milk thistle seeds, has been used for centuries to treat hepatic conditions. Preclinical data indicate that silymarin can reduce oxidative stress and consequent cytotoxicity, thereby protecting intact liver cells or cells not yet irreversibly damaged (...) Silymarin acts as a free radical scavenger and modulates enzymes associated with the development of cellular damage, fibrosis and cirrhosis. (...) Silymarin is generally very well tolerated, with a low incidence of adverse events and no treatment-related serious adverse events or deaths reported in clinical trials.
@lexcellencehealth Жыл бұрын
關於 GSH,可參考此篇文獻:pubmed.ncbi.nlm.nih.gov/37035339/ The pathogenetic role of oxidative stress in NALFD is well known and would explain the rationale for the use of GSH as a potential therapy. The studies currently available on the use of both oral and parenteral GSH are promising but represent only pilot studies for the time being. 口服 GSH 的部分主要是留意吸收率的問題。